EASTMAN KODAK &lt;EK> SELL HOLDINGS Eastman Kodak plans sell 2.3 pct holding ICN Pharmaceuticals &lt;ICN> part pct holdings Viratek &lt;VIRA>. purpose investments lay groundwork creation Nucleic Acid Research Institute. achieved, longer reason maintain equity positions, Kodak said. Kodak holds 470,000 sahres ICN, trading 18-3/4 700,000 Viratek, trading 44.